使用微生物组诊断克罗恩病和性结肠炎
Da-Yeon Kang1,2, Jong-Lyul Park3, Min-Kyung Yeo4
1Department of New Drug Development, Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, Korea.
BMC microbiology
|November 11, 2023
概括
这项研究使用肠道微生物组数据区分了克罗恩病 (CD) 和性结肠炎 (UC). 确定了特定的细菌生物标志物,有助于诊断这些炎症性肠病 (IBD) 和评估疾病严重程度.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 生物信息学是一种生物信息学.
背景情况:
- 炎症性肠病 (IBD) 包括克罗恩病 (CD) 和性结肠炎 (UC),其特点是免疫失调和肠道微生物群的改变.
- 区分CD和UC对于有效的长期患者管理至关重要.
- 肠道微生物组的改变与IBD严重程度有关.
研究的目的:
- 使用微生物组分析来区分CD和UC.
- 为了确定与IBD疾病活动相关的特定微生物生物标志物.
- 根据便微生物组数据开发CD和UC的诊断模型.
主要方法:
- 便全元基因组 (WMS) 测序被用来分析肠道微生物组.
- 机器学习模型,包括规范后勤回归,被用于差异诊断.
- 用曲线下的面积 (AUC) 和精度回忆曲线下的面积 (PRAUC) 来评估模型性能.
主要成果:
- 在IBD患者和健康对照者之间观察到肠道微生物群多样性和组成的显著差异,CD患者表现出较低的多样性.
- 68个微生物成员被确定与CD和UC相关.
- 特定的细菌丰度与CD和UC的疾病严重程度相关.
- 开发的模型在训练组中实现了0.873的AUC,用于歧视CD和UC.
结论:
- 便全元基因组猎枪测序和机器学习可以有效地诊断CD和UC.
- 拟议的微生物组生物标志物与IBD的疾病活性有关.
- 这种方法为IBD诊断和严重程度评估提供了一种新的方法.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
338
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
338
Inflammatory Bowel Disease I: Ulcerative Colitis
192
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
192
Inflammatory Bowel Disease II: Crohn's Disease
259
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
259
Serum Laboratory Studies, Stool Test, Breath Test
354
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
354
Chronic Bowel Disorders: Introduction
458
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
458
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170


